ARCHIVES

Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.”

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Professional Societies: ASCO opposes FDA On Stem Cell Transplant Regs

May 16, 1997

In Brief: McDonnell Foundation Awards Four Fellowships; UCLA’s Kenneth Shine Is Next IOM President

January 10, 1992

CMS Removes Obstacles for Contractors to Deny EPO Coverage for Cancer Anemia.

March 9, 2007

Healy’s Boxes Packed, When Word Came That She Could Stay

January 29, 1993

EORTC Screening, Pharmacology Group Focuses On CNU

January 2, 1987

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006